You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

46 Results
These frequently asked questions give patients and their families information about the services and safeguards we use for our web-based symptom...
Guidelines and Advice
Status: Current
ID: GL-C50-15
Dec 1969
Drug
Other Name(s): Kadcyla®
Dec 1969
Regimen
Intent: Palliative
Funding:
New Drug Funding Program
    Trastuzumab Emtansine - Unresectable Locally Advanced or Metastatic Breast Cancer
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Intent: Curative
Document
Document
Dec 1969
Document

Pages